Jul 2022

4 July: Coming to terms with long COVID; Vaxes for variants; An artificial pancreas; Protecting pandemic teens

Australia has many stories from people who say they have long COVID but who are unable to access help | Updated versions of coronavirus vaccines targeting the Omicron variant have been announced, yet the virus still mutates | People with Type 1 diabetes need to monitor their bloo ... Show More

28m 35s

Jun 2022

Speculating on an Australian Centre of Disease Control and Prevention; How Indigenous culture can protect the heart; Associations between mental health and mortality

What an Australian Centre for Disease Control might aim to be; An Indigenous perspective and research to engage culture for protection against cardiovascular disease and stroke; Research on links between mental health and mortality concludes that both mental and physical health c ... Show More

28m 35s

Jun 2022

Breast density and MRIs, diet and mental health, genomics and osteoarthritis

There may be a link between what you eat and your mental health—also, avoiding overtreatment for breast cancer; predicting your risk of osteoarthritis; and whether mammogram results should inform women about breast density.

28m 35s

Jun 2021

FDA Approves Aducanumab — A Controversial Drug For Alzheimer's

The FDA has approved a new drug for Alzheimer's. But a lot of experts are skeptical about whether the drug works. Rhitu Chatterjee talks with science correspondent Jon Hamilton about the controversial drug aducanumab and why the U.S. Food and Drug Administration approved it. For ... Show More

11m 52s

Aug 2021

Controversial new Alzheimer's drug in the spotlight

After decades without progress, this June a new treatment was approved by the US Food and Drugs Administration - Biogen's Aduhelm. Ivana Davidovic looks into why this process has been so controversial that is now under investigation by a federal watchdog.Aaron Kesselheim, a Harva ... Show More

18m 21s

Jul 2021

'Some Hope Is Better Than Having No Hope'

<p>When the F.D.A. approved the drug Aduhelm, the first Alzheimer’s treatment to receive the agency’s endorsement in almost two decades, it gave hope to many.</p><p>But the decision was contentious; some experts say there’s not enough evidence that the treatment can address cogni ... Show More

36m 59s

Feb 2024

The 2 Minute Medicine® Podcast- Episode 35

<p>We begin with a discussion about our article of the week which comes from The Lancet and is entitled “Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-c ... Show More

11m 48s

Mar 2023

How Well Does A New Alzheimer's Drug Work For Those Most At Risk?

A new drug for Alzheimer's disease, called lecanemab, got a lot of attention earlier this year for getting fast-tracked approval based on a clinical trial that included nearly 1,800 people. It was the most diverse trial for an Alzheimer's treatment to date, but still not enough t ... Show More

13m 46s

Aug 2023

What difference could new Alzheimer’s disease drugs make?

Until recently, breakthroughs in treating Alzheimer’s disease were non-existent. But two new drugs have shown promise in moderately slowing memory and thinking problems for people with early-stage disease. While welcoming the idea of a ‘new era’ for treating Alzheimer’s disease, ... Show More

28m 37s

Alzheimer’s drug has experts divided; ri...